NKX3.1 - Revision history

Michael at 18:06, 9 April 2025

2025-04-09T18:06:30Z

← Older revision		Revision as of 18:06, 9 April 2025
Line 8:		Line 8:
	*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>		*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>
	*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>		*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>
	*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal \| last1 = Abdo \| first1 = M \| last2 = Hoyt \| first2 = R \| last3 = Highfill \| first3 = A \| last4 = Mettman \| first4 = D \| title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall \| journal = Human Pathology Reports \| volume = 27 \| issue = \| pages = \| month = Mar \| year = 2022 \| doi = 10.1016/j.hpr.2022.300599 \| PMID = \| PMC = \| url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref>		*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal \| last1 = Abdo \| first1 = M. \| last2 = Hoyt \| first2 = R. \| last3 = Highfill \| first3 = A. \| last4 = Mettman \| first4 = D. \| title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall \| journal = Human Pathology Reports \| volume = 27 \| issue = \| pages = \| month = Mar \| year = 2022 \| doi = 10.1016/j.hpr.2022.300599 \| PMID = \| PMC = \| url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref>

	==See also==		==See also==

Michael at 18:04, 9 April 2025

2025-04-09T18:04:44Z

← Older revision		Revision as of 18:04, 9 April 2025
Line 8:		Line 8:
	*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>		*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>
	*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>		*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>
	*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal \| last1 = Abdo \| first1 = M \| last2 = Hoyt \| first2 = R \| title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall \| journal = \| volume = \| issue = \| pages = \| month = \| year = \| doi = 10.1016/j.hpr.2022.300599 \| PMID = \| PMC = \| url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref>		*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal \| last1 = Abdo \| first1 = M \| last2 = Hoyt \| first2 = R \| last3 = Highfill \| first3 = A \| last4 = Mettman \| first4 = D \| title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall \| journal = Human Pathology Reports \| volume = 27 \| issue = \| pages = \| month = Mar \| year = 2022 \| doi = 10.1016/j.hpr.2022.300599 \| PMID = \| PMC = \| url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref>

	==See also==		==See also==

Michael at 18:02, 9 April 2025

2025-04-09T18:02:46Z

← Older revision		Revision as of 18:02, 9 April 2025
Line 8:		Line 8:
	*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>		*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal \| last1 = Asch-Kendrick \| first1 = RJ. \| last2 = Samols \| first2 = MA. \| last3 = Lilo \| first3 = MT. \| last4 = Subhawong \| first4 = AP. \| last5 = Sharma \| first5 = R. \| last6 = Illei \| first6 = PB. \| last7 = Argani \| first7 = P. \| last8 = Cimino-Mathews \| first8 = A. \| title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. \| journal = J Clin Pathol \| volume = 67 \| issue = 9 \| pages = 768-71 \| month = Sep \| year = 2014 \| doi = 10.1136/jclinpath-2014-202272 \| PMID = 24996432 }}</ref>
	*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>		*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>
			*Urothelial carcinoma with glandular differentiation.<ref>{{Cite journal \| last1 = Abdo \| first1 = M \| last2 = Hoyt \| first2 = R \| title = Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall \| journal = \| volume = \| issue = \| pages = \| month = \| year = \| doi = 10.1016/j.hpr.2022.300599 \| PMID = \| PMC = \| url = https://www.sciencedirect.com/science/article/pii/S2772736X22000111 }}</ref>

	==See also==		==See also==

Michael at 05:32, 21 October 2015

2015-10-21T05:32:44Z

← Older revision		Revision as of 05:32, 21 October 2015
Line 3:		Line 3:

	==Positive==		==Positive==
	*[[Prostatic carcinoma]].<ref>{{Cite journal \| last1 = Gordetsky \| first1 = J. \| last2 = Epstein \| first2 = JI. \| title = Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. \| journal = Am J Surg Pathol \| volume = 38 \| issue = 7 \| pages = 941-5 \| month = Jul \| year = 2014 \| doi = 10.1097/PAS.0000000000000178 \| PMID = 24503758 }}</ref>		*[[Prostatic carcinoma]].<ref name=pmid24503758>{{Cite journal \| last1 = Gordetsky \| first1 = J. \| last2 = Epstein \| first2 = JI. \| title = Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. \| journal = Am J Surg Pathol \| volume = 38 \| issue = 7 \| pages = 941-5 \| month = Jul \| year = 2014 \| doi = 10.1097/PAS.0000000000000178 \| PMID = 24503758 }}</ref>

	===Rarely positive===		===Rarely positive===

Michael at 04:34, 21 October 2015

2015-10-21T04:34:42Z

← Older revision		Revision as of 04:34, 21 October 2015
Line 1:		Line 1:
			[[Image:Urothelial carcinoma-like prostatic carcinoma - NKX3.1 -- intermed mag.jpg\|thumb\|right\|NKX3.1 staining in prostate carcinoma.]]
	'''NKX3.1''' is a relatively new [[immunostain]] for [[prostate cancer]].		'''NKX3.1''' is a relatively new [[immunostain]] for [[prostate cancer]].

Michael: create

2015-10-21T04:33:29Z

create

New page

'''NKX3.1''' is a relatively new [[immunostain]] for [[prostate cancer]].

==Positive==
*[[Prostatic carcinoma]].<ref>{{Cite journal | last1 = Gordetsky | first1 = J. | last2 = Epstein | first2 = JI. | title = Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. | journal = Am J Surg Pathol | volume = 38 | issue = 7 | pages = 941-5 | month = Jul | year = 2014 | doi = 10.1097/PAS.0000000000000178 | PMID = 24503758 }}</ref>

===Rarely positive===
*[[Invasive ductal carcinoma of the breast]] ~2% of cases.<ref name=pmid24996432>{{Cite journal | last1 = Asch-Kendrick | first1 = RJ. | last2 = Samols | first2 = MA. | last3 = Lilo | first3 = MT. | last4 = Subhawong | first4 = AP. | last5 = Sharma | first5 = R. | last6 = Illei | first6 = PB. | last7 = Argani | first7 = P. | last8 = Cimino-Mathews | first8 = A. | title = NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. | journal = J Clin Pathol | volume = 67 | issue = 9 | pages = 768-71 | month = Sep | year = 2014 | doi = 10.1136/jclinpath-2014-202272 | PMID = 24996432 }}</ref>
*[[Invasive lobular carcinoma]] ~10% of cases.<ref name=pmid24996432/>

==See also==
*[[Immunohistochemistry]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]